In this section
@article{Yii:2017:10.2741/s477,
author = {Yii, AC and Koh, MS and Lapperre, TS and Tan, GL and Chotirmall, SH},
doi = {10.2741/s477},
journal = {Front Biosci (Schol Ed)},
pages = {127--138},
title = {The emergence of Aspergillus species in chronic respiratory disease.},
url = {http://dx.doi.org/10.2741/s477},
volume = {9},
year = {2017}
}
TY - JOUR
AB - Chronic lung disease is recognized as an important risk factor for developing pulmonary aspergillosis. The development of specific aspergillus-associated syndromes depends on host immunity and underlying lung disease. In the setting of asthma, hypersensitivity to Aspergillus can lead to allergic bronchopulmonary aspergillosis (ABPA) or severe asthma with fungal sensitization (SAFS). Chronic use of systemic or inhaled corticosteroids coupled with recurrent antibiotic use for exacerbations prevalent in chronic obstructive pulmonary disease (COPD) predisposes to chronic pulmonary aspergillosis (CPA). Prior pulmonary tuberculosis is a risk factor for CPA, a syndrome with a wide range of presentations including a simple aspergilloma, chronic cavities, necrosis or fibrosis. Accumulating evidence suggests that the presence of or colonization by Aspergillus in the setting of chronic lung disease can worsen clinical course and outcomes even in the absence of overt pulmonary aspergillosis. We propose that understanding the complex interplay between host and fungi may provide key insights into the pathogenesis of Aspergillus-associated pulmonary syndromes in the setting of chronic lung disease, and provide novel therapeutic approaches to improve its identification and management.
AU - Yii,AC
AU - Koh,MS
AU - Lapperre,TS
AU - Tan,GL
AU - Chotirmall,SH
DO - 10.2741/s477
EP - 138
PY - 2017///
SP - 127
TI - The emergence of Aspergillus species in chronic respiratory disease.
T2 - Front Biosci (Schol Ed)
UR - http://dx.doi.org/10.2741/s477
UR - https://www.ncbi.nlm.nih.gov/pubmed/27814579
VL - 9
ER -
For any enquiries about the Fungal Science Network at Imperial, please contact: